Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1988 Dec;82(6):1963–1973. doi: 10.1172/JCI113816

Proteinase 3. A distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamsters.

R C Kao 1, N G Wehner 1, K M Skubitz 1, B H Gray 1, J R Hoidal 1
PMCID: PMC442778  PMID: 3198760

Abstract

Studies were designed to explore the possibility that human polymorphonuclear leukocyte granule constituents in addition to elastase (HLE) had the potential to cause emphysema. A two-step purification of three serine proteinases was developed. Granule extract proteins were initially separated by dye-ligand affinity chromatography. Fractions eluted were divided into four pools. Hamsters were given a single intratracheal instillation of saline +/- 0.1 mg protein of each pool. While pool 2 contained HLE and cathepsin G, the most dramatic bullous emphysema developed in animals treated with pool 4. The esterase from pool 4, designated proteinase 3 (PR-3) was purified, characterized in vitro, and tested for its ability to cause emphysema. PR-3 is a neutral serine proteinase with isoenzyme forms. Its ability to degrade elastin at pH 6.5 is slightly greater than that of HLE, but it is less active than HLE at pH 7.4 or 8.9. PR-3 has weak activity against azocasein. Its ability to degrade hemoglobin is intermediate to that of HLE and cathepsin G at pH 7.4. PR-3 has no activity against chromogenic substrates specific for HLE or cathepsin G. Its pI is substantially less than HLE or cathepsin G. It is also immunologically distinct from HLE. It induces emphysema in hamsters commensurate with that of HLE. We conclude that PR-3 may be important in the pathogenesis of human emphysema.

Full text

PDF
1966

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baggiolini M., Bretz U., Dewald B., Feigenson M. E. The polymorphonuclear leukocyte. Agents Actions. 1978 Jan;8(1-2):3–10. doi: 10.1007/BF01972395. [DOI] [PubMed] [Google Scholar]
  2. Barrett A. J. A new assay for cathepsin B1 and other thiol proteinases. Anal Biochem. 1972 May;47(1):280–293. doi: 10.1016/0003-2697(72)90302-8. [DOI] [PubMed] [Google Scholar]
  3. Barrett A. J. Cathepsin G. Methods Enzymol. 1981;80(Pt 100):561–565. doi: 10.1016/s0076-6879(81)80044-4. [DOI] [PubMed] [Google Scholar]
  4. Blackwood C. E., Hosannah Y., Perman E., Keller S., Mandl I. Experimental emphysema in rats: elastolytic titer of inducing enzyme as determinant of the response. Proc Soc Exp Biol Med. 1973 Nov;144(2):450–454. doi: 10.3181/00379727-144-37610. [DOI] [PubMed] [Google Scholar]
  5. Blow A. M. Action of human lysosomal elastase on the oxidized B chain of insulin. Biochem J. 1977 Jan 1;161(1):13–16. doi: 10.1042/bj1610013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Blow A. M., Barrett A. J. Action of human cathepsin G on the oxidized B chain of insulin. Biochem J. 1977 Jan 1;161(1):17–19. doi: 10.1042/bj1610017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Boudier C., Holle C., Bieth J. G. Stimulation of the elastolytic activity of leukocyte elastase by leukocyte cathepsin G. J Biol Chem. 1981 Oct 25;256(20):10256–10258. [PubMed] [Google Scholar]
  8. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  9. Campbell E. J. Preventive therapy of emphysema. Lessons from the elastase model. Am Rev Respir Dis. 1986 Sep;134(3):435–437. doi: 10.1164/arrd.1986.134.3.435. [DOI] [PubMed] [Google Scholar]
  10. Chapman H. A., Jr, Stone O. L. Co-operation between plasmin and elastase in elastin degradation by intact murine macrophages. Biochem J. 1984 Sep 15;222(3):721–728. doi: 10.1042/bj2220721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gunja-Smith Z. An enzyme-linked immunosorbent assay to quantitate the elastin crosslink desmosine in tissue and urine samples. Anal Biochem. 1985 May 15;147(1):258–264. doi: 10.1016/0003-2697(85)90036-3. [DOI] [PubMed] [Google Scholar]
  12. HUMMEL B. C. A modified spectrophotometric determination of chymotrypsin, trypsin, and thrombin. Can J Biochem Physiol. 1959 Dec;37:1393–1399. [PubMed] [Google Scholar]
  13. Hartree E. F. Determination of protein: a modification of the Lowry method that gives a linear photometric response. Anal Biochem. 1972 Aug;48(2):422–427. doi: 10.1016/0003-2697(72)90094-2. [DOI] [PubMed] [Google Scholar]
  14. Hovde C. J., Gray B. H. Characterization of a protein from normal human polymorphonuclear leukocytes with bactericidal activity against Pseudomonas aeruginosa. Infect Immun. 1986 Oct;54(1):142–148. doi: 10.1128/iai.54.1.142-148.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Janoff A., Carp H., Laurent P., Raju L. The role of oxidative processes in emphysema. Am Rev Respir Dis. 1983 Feb;127(2):S31–S38. doi: 10.1164/arrd.1983.127.2P2.S31. [DOI] [PubMed] [Google Scholar]
  16. Janoff A., Dearing R. Prevention of elastase-induced experimental emphysema by oral administration of a synthetic elastase inhibitor. Am Rev Respir Dis. 1980 Jun;121(6):1025–1029. doi: 10.1164/arrd.1980.121.6.1025. [DOI] [PubMed] [Google Scholar]
  17. Janoff A., Sloan B., Weinbaum G., Damiano V., Sandhaus R. A., Elias J., Kimbel P. Experimental emphysema induced with purified human neutrophil elastase: tissue localization of the instilled protease. Am Rev Respir Dis. 1977 Mar;115(3):461–478. doi: 10.1164/arrd.1977.115.3.461. [DOI] [PubMed] [Google Scholar]
  18. Keiser H., Greenwald R. A., Feinstein G., Janoff A. Degradation of cartilage proteoglycan by human leukocyte granule neutral proteases--a model of joint injury. II. Degradation of isolated bovine nasal cartilage proteoglycan. J Clin Invest. 1976 Mar;57(3):625–632. doi: 10.1172/JCI108318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kleinerman J., Ranga V., Rynbrandt D., Sorensen J., Powers J. C. The effect of the specific elastase inhibitor, alanyl alanyl prolyl alanine chloromethylketone, on elastase-induced emphysema. Am Rev Respir Dis. 1980 Feb;121(2):381–387. doi: 10.1164/arrd.1980.121.2.381. [DOI] [PubMed] [Google Scholar]
  20. Kuhn C., 3rd, Starcher B. C. The effect of lathyrogens on the evolution of elastase-induced emphysema. Am Rev Respir Dis. 1980 Sep;122(3):453–460. doi: 10.1164/arrd.1980.122.3.453. [DOI] [PubMed] [Google Scholar]
  21. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  22. Lonky S. A., Wohl H. Regulation of elastolysis of insoluble elastin by human leukocyte elastase: stimulation by lysine-rich ligands, anionic detergents, and ionic strength. Biochemistry. 1983 Jul 19;22(15):3714–3720. doi: 10.1021/bi00284a027. [DOI] [PubMed] [Google Scholar]
  23. Lonky S. A., Wohl H. Stimulation of human leukocyte elastase by platelet factor 4. Physiologic, morphologic, and biochemical effects on hamster lungs in vitro. J Clin Invest. 1981 Mar;67(3):817–826. doi: 10.1172/JCI110099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Lucey E. C., Stone P. J., Breuer R., Christensen T. G., Calore J. D., Catanese A., Franzblau C., Snider G. L. Effect of combined human neutrophil cathepsin G and elastase on induction of secretory cell metaplasia and emphysema in hamsters, with in vitro observations on elastolysis by these enzymes. Am Rev Respir Dis. 1985 Aug;132(2):362–366. doi: 10.1164/arrd.1985.132.2.362. [DOI] [PubMed] [Google Scholar]
  25. Mainardi C. L., Dixit S. N., Kang A. H. Degradation of type IV (basement membrane) collagen by a proteinase isolated from human polymorphonuclear leukocyte granules. J Biol Chem. 1980 Jun 10;255(11):5435–5441. [PubMed] [Google Scholar]
  26. Mainardi C. L., Hasty D. L., Seyer J. M., Kang A. H. Specific cleavage of human type III collagen by human polymorphonuclear leukocyte elastase. J Biol Chem. 1980 Dec 25;255(24):12006–12010. [PubMed] [Google Scholar]
  27. McDonald J. A., Kelley D. G. Degradation of fibronectin by human leukocyte elastase. Release of biologically active fragments. J Biol Chem. 1980 Sep 25;255(18):8848–8858. [PubMed] [Google Scholar]
  28. Powers J. C., Bengali Z. H. Elastase inhibitors for treatment of emphysema. Approaches to synthesis and biological evaluation. Am Rev Respir Dis. 1986 Nov;134(5):1097–1100. doi: 10.1164/arrd.1986.134.5.1097. [DOI] [PubMed] [Google Scholar]
  29. Rao C. N., Margulies I. M., Goldfarb R. H., Madri J. A., Woodley D. T., Liotta L. A. Differential proteolytic susceptibility of laminin alpha and beta subunits. Arch Biochem Biophys. 1982 Nov;219(1):65–70. doi: 10.1016/0003-9861(82)90134-5. [DOI] [PubMed] [Google Scholar]
  30. Reilly C. F., Fukunaga Y., Powers J. C., Travis J. Effect of neutrophil cathepsin G on elastin degradation by neutrophil elastase. Hoppe Seylers Z Physiol Chem. 1984 Sep;365(9):1131–1135. doi: 10.1515/bchm2.1984.365.2.1131. [DOI] [PubMed] [Google Scholar]
  31. Reilly C. F., Travis J. The degradation of human lung elastin by neutrophil proteinases. Biochim Biophys Acta. 1980 Jan 24;621(1):147–157. doi: 10.1016/0005-2795(80)90070-7. [DOI] [PubMed] [Google Scholar]
  32. Riley D. J., Kerr J. S. Oxidant injury of the extracellular matrix: potential role in the pathogenesis of pulmonary emphysema. Lung. 1985;163(1):1–13. doi: 10.1007/BF02713801. [DOI] [PubMed] [Google Scholar]
  33. Schumacher G. F., Schill W. B. Radial diffusion in gel for micro determination of enzymes. II. Plasminogen activator, elastase, and nonspecific proteases. Anal Biochem. 1972 Jul;48(1):9–26. doi: 10.1016/0003-2697(72)90165-0. [DOI] [PubMed] [Google Scholar]
  34. Senior R. M., Tegner H., Kuhn C., Ohlsson K., Starcher B. C., Pierce J. A. The induction of pulmonary emphysema with human leukocyte elastase. Am Rev Respir Dis. 1977 Sep;116(3):469–475. doi: 10.1164/arrd.1977.116.3.469. [DOI] [PubMed] [Google Scholar]
  35. Skubitz K. M., August J. T. Characterization of cell surface glycoproteins recognized by the granulocyte-specific monoclonal antibody, AHN-1. Arch Biochem Biophys. 1985 Apr;238(1):263–271. doi: 10.1016/0003-9861(85)90164-x. [DOI] [PubMed] [Google Scholar]
  36. Starcher B. C., Galione M. J. Purification and comparison of elastins from different animal species. Anal Biochem. 1976 Aug;74(2):441–447. doi: 10.1016/0003-2697(76)90224-4. [DOI] [PubMed] [Google Scholar]
  37. Starkey P. M., Barrett A. J. Neutral proteinases of human spleen. Purification and criteria for homogeneity of elastase and cathepsin G. Biochem J. 1976 May 1;155(2):255–263. doi: 10.1042/bj1550255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Stone P. J., Franzblau C., Kagan H. M. Proteolysis of insoluble elastin. Methods Enzymol. 1982;82(Pt A):588–605. doi: 10.1016/0076-6879(82)82089-2. [DOI] [PubMed] [Google Scholar]
  39. Stone P. J., Lucey E. C., Calore J. D., Snider G. L., Franzblau C., Castillo M. J., Powers J. C. The moderation of elastase-induced emphysema in the hamster by intratracheal pretreatment or post-treatment with succinyl alanyl alanyl prolyl valine chloromethyl ketone. Am Rev Respir Dis. 1981 Jul;124(1):56–59. doi: 10.1164/arrd.1981.124.1.56. [DOI] [PubMed] [Google Scholar]
  40. Taylor J. C., Crawford I. P. Purification and preliminary characterization of human leukocyte elastasel. Arch Biochem Biophys. 1975 Jul;169(1):91–101. doi: 10.1016/0003-9861(75)90320-3. [DOI] [PubMed] [Google Scholar]
  41. Thomas J. M., Hodes M. E. A new discontinuous buffer system for the electrophoresis of cationic proteins at near-neutral pH. Anal Biochem. 1981 Nov 15;118(1):194–196. doi: 10.1016/0003-2697(81)90178-0. [DOI] [PubMed] [Google Scholar]
  42. Thurlbeck W. M. The internal surface area of nonemphysematous lungs. Am Rev Respir Dis. 1967 May;95(5):765–773. doi: 10.1164/arrd.1967.95.5.765. [DOI] [PubMed] [Google Scholar]
  43. Travis J., Giles P. J., Porcelli L., Reilly C. F., Baugh R., Powers J. Human leucocyte elastase and cathepsin G: structural and functional characteristics. Ciba Found Symp. 1979;(75):51–68. doi: 10.1002/9780470720585.ch4. [DOI] [PubMed] [Google Scholar]
  44. Vartio T., Seppä H., Vaheri A. Susceptibility of soluble and matrix fibronectins to degradation by tissue proteinases, mast cell chymase and cathepsin G. J Biol Chem. 1981 Jan 10;256(1):471–477. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES